Study of ESG401 in Adults With Solid Tumors

NCT04892342 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast
Neoplasms, Lung
Neoplasms,Colorectal
Neoplasms, Bladder
Neoplasm of Stomach
Neoplasms,Ovarian

Interventions

DRUG: ESG401

Sponsor

Shanghai Escugen Biotechnology Co., Ltd